Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center Study of the Chinese Medicine for the Treatment of MDR Membranous Nephropathy in the Traditional Chinese Medicine (a Herbal Formula for Invigorating Spleen and Benefiting qi and Promoting Blood Circulation)

NCT02610595 is registered in ClinicalTrials.gov with Shanghai University of Traditional Chinese Medicine as lead sponsor.

NCT NCT02610595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02610595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center Study of the Chinese Medicine for the Treatment of MDR Membranous Nephropathy in the Traditional Chinese Medicine (a Herbal Formula for Invigorating Spleen and Benefiting qi and Promoting Blood Circulation)
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2015
Completion date
December 31, 2016
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic membranous nephropathy